Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000733519 | SCV000861596 | uncertain significance | not provided | 2018-05-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000799960 | SCV000939653 | uncertain significance | Niemann-Pick disease, type C1 | 2022-02-17 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1044 of the NPC1 protein (p.Val1044Met). This variant is present in population databases (rs767343173, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with NPC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 597412). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000799960 | SCV002816477 | uncertain significance | Niemann-Pick disease, type C1 | 2022-04-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000799960 | SCV001453833 | uncertain significance | Niemann-Pick disease, type C1 | 2020-09-16 | no assertion criteria provided | clinical testing |